John joined PHARMAC in 2012 as a deputy medical director with particular responsibility for secondary care, leading PHARMAC’s clinical interactions around hospital medicines and hospital medical devices.
He was appointed Medical Director in 2013, and leads the team that provides clinical input to PHARMAC, including through the Pharmacology and Therapeutics Advisory Committee. The team interacts with clinicians across both the primary and secondary care sectors.